The Blood Screening Market is expected to grow at a CAGR of 6.9% from 2020 to 2027 to reach $3.56 billion by 2027. Blood screening is one of the most ideal and preferred tests for diagnosing various infectious diseases. Blood screening enables physicians to diagnose diseases effectively, which helps in administering suitable treatments and monitoring the patient to avoid the spread of the disease.
Factors such as the rise in blood donations and blood transfusion-related screenings, increasing prevalence of infectious diseases, growing geriatric population, and increasing awareness about transfusion-transmitted diseases are driving the growth of this market. Untapped emerging markets such as India and China and advancements in technology hold great opportunities for this market to grow during the forecast period.
However, the lack of legislation, regulation, and policies regarding blood transfusion-related activities in some countries and the development of alternative technologies replacing blood screening are expected to hinder the growth of this market to a certain extent.
The Impact of COVID-19 on the Blood Screening Market
The COVID-19 pandemic has influenced the blood screening market both positively and negatively. The outbreak of COVID-19 led to the immediate development of several serological tests to detect COVID-19 antibodies by many companies. For instance, the U.S. FDA granted Emergency Use Authorization (EUA) to about 50 serological tests to detect COVID-19 antibodies. These tests are intended to study the seroprevalence of the virus in a given population. Moreover, there has been a drastic increase in the number of hospitalizations, which is expected to increase the demand for donated blood or its components and positively influence the blood screening market.
In August 2020, the U.S. FDA issued an emergency use authorization (EUA) for the convalescent plasma treatment for COVID-19 in hospitalized patients. The patients who survived the COVID-19 infection have high levels of IgG antibodies against the virus in their plasma. Hence their plasma can be extracted and used to treat other COVID-19 patients. The FDA commissioner encouraged COVID-19 survivors to donate plasma since April 2020. The demand for plasma treatment is rising along with the number of plasma donations worldwide. All the donated plasma must be screened for various infectious diseases and blood typing tests. Therefore, this factor is expected to positively impact the blood screening market.
However, the number of blood donations and blood transfusion-related screenings has taken a hit due to the lockdown and restrictions imposed during the pandemic. The number of blood donations reduced significantly due to the lockdowns and the fear of getting infected, which in turn reduced the blood transfusion-related screenings. However, the number of blood donations has increased since lockdown restrictions have been relaxed. The American Red Cross also began testing all blood, platelet, and plasma donations for COVID-19 antibodies to provide the donor insights into whether they have been exposed to the coronavirus.
Therefore, even though blood donations and transfusion-related screenings might have taken a hit during the peak months of the pandemic, the overall impact of COVID-19 is expected to contribute positively toward the growth of the blood screening market.
Click here to: Get Free Request Sample Copy of this report
Key Findings of the Blood Screening Market Study:
The Reagents & Kits Segment Dominated the Market
By product, the reagents & kits segment commanded the largest share of the blood screening market in 2020. Reagents being a recurrent expense, are extensively used for immunoassays and molecular tests. Factors such as increasing blood donations and transfusion-related screenings and the increasing prevalence of infectious diseases are driving the growth of this segment. Moreover, due to the outbreak of COVID-19, there has been an increase in serological testing, which has also contributed to the growth of this segment.
The Nucleic Acid Amplification Segment to Dominate the Market
By technology, the nucleic acid amplification segment commanded the largest share of the blood screening market in 2020. The largest share is attributed to the superior benefits of the technology, such as high sensitivity and specificity for early detection. Moreover, the widespread adoption of this technology in blood banks, hospitals, and clinical laboratories also contributes to its largest share. Additionally, the high adoption of this technology in emerging markets and developing countries provides great opportunities for the growth of this segment. However, requirements such as skilled labor and high-cost initial infrastructure are expected to pose challenges for the growth of this segment.
The Blood Banks Segment Dominated the Market
By End User, the blood banks segment commanded the largest share of the blood screening market. Laboratory screening of donated blood and blood products for infectious diseases is a key safety measure to protect patients and to prevent the spread of serious infectious diseases. Factors such as increasing blood donations and transfusion-related screenings, growing awareness about transfusion-transmitted infections, and the rising occurrence of infectious diseases are driving the growth of this segment.
North America: The Largest Regional Market
In 2020, North America dominated the blood screening market. North America’s largest share is primarily attributed to the increasing blood transfusion-related screenings, growing prevalence of infectious diseases, rising geriatric population, need for early disease diagnosis and monitoring, increasing healthcare expenditure, and the growing adoption of advanced blood screening technologies in the region.
Key Players
The report includes a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments by leading market players in the industry over the past four years. The key players profiled in the blood screening market are Abbott Laboratories (U.S.), OriGene Technologies, Inc. (U.S.), BioAim Scientific Inc. (Canada), bioMérieux, Inc. (France), Bio-Rad Laboratories, Inc. (U.S.), Grifols, S.A. (Spain), Immuno-Biological Laboratories Co., Ltd. (Japan), Biovision, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Boster Biological Technology (U.S.), Cusabio Technology LLC (U.S.), Danaher Corporation (U.S.), Demeditec Diagnostics GmbH (Germany), and F. Hoffmann-La Roche Ltd. (Switzerland), among others.
Scope of the Report:
Blood Screening Market, by Product
Blood Screening Market, by Technology
Blood Screening Market, by End User
Blood Screening Market, by Geography
Key Questions Answered in the Report:
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-Up Approach
2.3.1.2. Top-Down Approach
2.3.1.3. Growth forecast
2.3.2. Market Share Analysis
2.4. Assumptions for this Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Increasing Number of Blood Donations and Transfusion Related Screenings
4.2.2. Growing Prevalence of Infectious Diseases
4.2.3. Increasing Government Initiatives
4.3. Restraints
4.3.1. Lack of Legislation, Regulations, and Policies
4.3.2. Development of Alternative Technologies
4.4. Opportunities
4.4.1. Emerging Countries
4.4.2. Technological Advancements
4.5. Challenges
4.5.1. High Cost of NAT Tests in Developing Countries
4.6. Impact Assessment of Covid-19
5. Global Blood Screening Market, by Product
5.1. Introduction
5.2. Reagents & Kits
5.2.1. Nucleic Acid Amplification Test (NAAT)
5.2.2. ELISA
5.2.3. Other Reagents & Kits
5.3. Instruments
5.4. Software and Services
6. Global Blood Screening Market, by Technology
6.1. Introduction
6.2. Nucleic Acid Amplification (NAAT)
6.2.1. Transcription Mediated Amplification (TMA)
6.2.2. Real Time Polymerase Chain Reaction (RT-PCR)
6.3. Enzyme Linked Immunosorbent Assay (ELISA)
6.3.1. Chemiluminescent Immunoassay (CLIA)
6.3.2. Fluorescent Immunoassays (FIA)
6.3.3. Colorimetric Immunoassays (CI)
6.4. Rapid Tests
6.5. Western Blotting
6.6. Next Generation Sequencing (NGS)
7. Global Blood Screening Market, by End User
7.1. Introduction
7.2. Blood Banks
7.3. Hospitals
7.4. Clinical Laboratories
8. Global Blood Screening Market, by Geography
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe (RoE)
8.4. Asia-Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Rest of Asia-Pacific (RoAPAC)
8.5. Latin America
8.6. Middle East & Africa
9. Competitive Landscape
9.1. Introduction
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Market Share Analysis, by Key Player (2019)
9.4.1. Abbott Laboratories
9.4.2. Becton, Dickinson And Company
9.4.3. F. Hoffmann-La Roche Ltd
10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Development)
10.1. Abbott Laboratories
10.2. bioMerieux, Inc.
10.3. Bio-Rad Laboratories, Inc.
10.4. Grifols, S.A.
10.5. Becton, Dickinson And Company
10.6. F. Hoffmann-La Roche Ltd.
10.7. Boster Biological Technology
10.8. Cusabio Technology LLC
10.9. Danaher Corporation
10.10. Demeditec Diagnostics GmbH
11. Appendix
11.1. Questionnaire
11.2. Available Customization
List of Tables
Table 1 Global Blood Screening Market Drivers: Impact Analysis (2020-2027)
Table 2 Estimated Units of Blood Donations Collected Per Year
Table 3 List of Donor Blood Screening Tests
Table 4 Global Blood Screening Market Restraints: Impact Analysis (2020-2027)
Table 5 Percent of Countries Lacking National Blood Policy
Table 6 Covid-19 Confirmed Cases and Deaths across the World (21st December 2020)
Table 7 Recent Serological Tests Launched for Covid-19
Table 8 Global Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 9 Global Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 10 Global Blood Screening Reagents& Kits Market Size, by Country/Region, 2018-2027 (USD Million)
Table 11 Recent Approvals for NAT Reagents & Kits
Table 12 Key Companies Offering Blood Screening NAAT Reagents & Kits
Table 13 Global NAT Reagents & Kits Market Size, by Country/Region, 2018-2027 (USD Million)
Table 14 Recent Launches and Approvals for ELISA Reagents & Kits
Table 15 Key Companies Offering Blood Screening ELISA Reagents & Kits
Table 16 Global ELISA Reagents & Kits Market Size, by Country/Region, 2018-2027 (USD Million)
Table 17 Key Companies Offering Other Reagents & Kits
Table 18 Global Other Reagents & Kits Market Size, by Country/Region, 2018-2027 (USD Million)
Table 19 Recent Launches & Approvals for Instruments
Table 20 Key Companies Offering Blood Screening Instruments
Table 21 Global Blood Screening Instruments Market Size, by Country/Region, 2018-2027 (USD Million)
Table 22 Key Companies Offering Blood Screening Software and Services
Table 23 Global Blood Screening Software & Services Market Size, by Country/Region, 2018-2027 (USD Million)
Table 24 Global Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 25 Global NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 26 Global NAAT-based Blood Screening Market Size, by Country/Region, 2018-2027 (USD Million)
Table 27 Global Transcription-Mediated Amplification Market Size, by Country/Region, 2018-2027 (USD Million)
Table 28 Key Companies Offering Real-Time PCR-based Blood Screening Products
Table 29 Global Real-Time PCR-based Blood Screening Market Size, by Country/Region, 2018-2027 (USD Million)
Table 30 Global ELISA-Based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 31 Global ELISA-Based Blood Screening Market Size, by Country/Region, 2018-2027 (USD Million)
Table 32 Key Companies Offering CLIA-Based Products
Table 33 Global Chemiluminescent Immunoassay Market Size, by Country/Region, 2018-2027 (USD Million)
Table 34 Key Companies Offering FIA-Based Products
Table 35 Global Fluorescent Immunoassay Market Size, by Country/Region, 2018-2027 (USD Million)
Table 36 Key Companies Offering CI-Based Products
Table 37 Global Colorimetric Immunoassay Market Size, by Country/Region, 2018-2027 (USD Million)
Table 38 Key Companies Offering Rapid Test Products
Table 39 Global Rapid Tests Market Size, by Country/Region, 2018-2027 (USD Million)
Table 40 Key Companies Offering Western Blotting Based Product
Table 41 Global Western Blotting Market Size, by Country/Region, 2018-2027 (USD Million)
Table 42 Global Next Generation Sequencing Market Size, by Country/Region, 2018-2027 (USD Million)
Table 43 Global Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 44 Global Blood Screening Market Size for Blood Banks, by Country/Region, 2018-2027 (USD Million)
Table 45 Global Blood Screening Market Size for Hospitals, by Country/Region, 2018-2027 (USD Million)
Table 46 Global Blood Screening Market Size for Clinical Laboratories, by Country/Region, 2018-2027 (USD Million)
Table 47 Global Blood Screening Market Size, by Country/Region, 2018-2027 (USD Million)
Table 48 North America: Blood Screening Market Size, by Country, 2018-2027 (USD Million)
Table 49 North America: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 50 North America: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 51 North America: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 52 North America: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 53 North America: ELISA-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 54 North America: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 55 Blood Screening Tests Recommended by Centers for Disease Control & Prevention
Table 56 U.S.: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 57 U.S.: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 58 U.S.: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 59 U.S.: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 60 U.S.: Blood Screening ELISA Market Size, by Type, 2018-2027 (USD Million)
Table 61 U.S.: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 62 Canada: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 63 Canada: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 64 Canada: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 65 Canada: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 66 Canada: Blood Screening ELISA Market Size, by Type, 2018-2027 (USD Million)
Table 67 Canada: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 68 Europe: Blood Screening Market Size, by Country, 2018-2027 (USD Million)
Table 69 Europe: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 70 Europe: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 71 Europe: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 72 Europe: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 73 Europe: ELISA-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 74 Europe: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 75 Germany: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 76 Germany: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 77 Germany: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 78 Germany: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 79 Germany: ELISA-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 80 Germany: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 81 France: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 82 France: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 83 France: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 84 France: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 85 France: ELISA-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 86 France: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 87 U.K.: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 88 U.K.: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 89 U.K.: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 90 U.K.: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 91 U.K.: ELISA-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 92 U.K.: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 93 Italy: Cancer Prevalence 2020
Table 94 Italy: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 95 Italy: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 96 Italy: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 97 Italy: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 98 Italy: ELISA-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 99 Italy: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 100 Spain: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 101 Spain: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 102 Spain: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 103 Spain: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 104 Spain: ELISA-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 105 Spain: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 106 RoE: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 107 RoE: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 108 RoE: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 109 RoE: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 110 RoE: ELISA-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 111 RoE: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 112 Asia-Pacific: Blood Screening Market Size, by Country, 2018-2027 (USD Million)
Table 113 Asia-Pacific: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 114 Asia-Pacific: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 115 Asia-Pacific: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 116 Asia-Pacific: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 117 Asia Pacific: ELISA-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 118 Asia-Pacific: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 119 China: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 120 China: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 121 China: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 122 China: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 123 China: ELISA-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 124 China: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 125 Japan: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 126 Japan: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 127 Japan: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 128 Japan: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 129 Japan: ELISA-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 130 Japan: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 131 India: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 132 India: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 133 India: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 134 India: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 135 India: ELISA-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 136 India: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 137 Rest of Asia-Pacific: Number of Cases of Infectious Diseases in Major Countries
Table 138 RoAPAC: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 13 RoAPAC: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 140 RoAPAC: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 141 RoAPAC: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 142 RoAPAC: ELISA-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 143 RoAPAC: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 144 Latin America: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 145 Latin America: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 146 Latin America: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 147 Latin America: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 148 Latin America: ELISA-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 149 Latin America: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 150 Middle East & Africa: Blood Screening Market Size, by Product and Service, 2018-2027 (USD Million)
Table 151 Middle East & Africa: Blood Screening Reagents & Kits Market Size, by Type, 2018-2027 (USD Million)
Table 152 Middle East & Africa: Blood Screening Market Size, by Technology, 2018-2027 (USD Million)
Table 153 Middle East & Africa: NAAT-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 154 Middle East & Africa: ELISA-based Blood Screening Market Size, by Type, 2018-2027 (USD Million)
Table 155 Middle East & Africa: Blood Screening Market Size, by End User, 2018-2027 (USD Million)
Table 156 Recent Developments, by Company, 2017-2020
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side& Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Global Blood Screening Market Size, by Product and Service, 2020 Vs. 2027 ($Million)
Figure 8 Global Blood Screening Market Size, by Technology, 2020 Vs. 2027 ($Million)
Figure 9 Blood Banks Segment Expected to Dominate the Global Blood Screening Market, by End User, (2020-2027)
Figure 10 Blood Screening Market, by Region
Figure 11 Market Dynamics
Figure 12 Global Blood Screening Market Size, by Product and Service, 2020-2027 (USD Million)
Figure 13 Global Blood Screening Market Size, by Technology, 2020-2027 (USD Million)
Figure 14 Global Blood Screening Market Size, by End User, 2020-2027 (USD Million)
Figure 15 Global Blood Screening Market Size, by Geography, 2020-2027 (USD Million)
Figure 16 North America: Blood Screening Market Snapshot
Figure 17 Europe: Blood Screening Market Snapshot
Figure 18 Asia-Pacific: Blood Screening Market Snapshot
Figure 19 Middle East & Africa: Road Fatalities per 100,000 per Year
Figure 20 Key Growth Strategies Adopted by Leading Players, 2017-2020
Figure 21 Blood Screening: Competitive Benchmarking
Figure 22 Geographic Competitive Benchmarking: Blood Screening Market
Figure 23 Market Share Analysis: Blood Screening Industry, 2019
Figure 24 Abbott Laboratories: Financial Overview (2019)
Figure 25 bioMerieux, Inc.: Financial Overview (2019)
Figure 26 Bio-Rad Laboratories, Inc.: Financial Overview (2019)
Figure 27 Grifols, S.A.: Financial Overview (2019)
Figure 28 Becton, Dickinson and Company: Financial Overview (2019)
Figure 29 F. Hoffmann-La Roche Ltd: Financial Overview (2019)
Figure 30 Danaher Corporation: Financial Overview (2019)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Jan-2023
Published Date: Jan-2023
Published Date: Jan-2023
